Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation.

Liang-He LuJie MeiAnna KanYi-Hong LingShao-Hua LiWei WeiMin-Shan ChenYong-Fa ZhangRong-Ping Guo

Published in: Cancer medicine (2020)

Compared with RFA, RHR provided a survival advantage for recurrent HCC, especially for patients who relapsed within 2 years and those with primary tumor burden beyond the Milan criteria.

Keyphrases

radiofrequency ablation
acute lymphoblastic leukemia
multiple myeloma
diffuse large b cell lymphoma
hodgkin lymphoma
combination therapy
free survival
replacement therapy